In the ever-evolving landscape of healthcare, the 340B Drug Pricing Program stands out as a crucial element for enabling healthcare providers to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services to maximize 340B savings. Enacted in 1992, the 340B program allows eligible healthcare organizations, referred to as ‘covered entities,’ to obtain outpatient drugs at significantly reduced prices.

However, navigating the complexities of the 340B program can be daunting. To truly maximize the savings and benefits the program offers, it’s essential to implement strategic practices that ensure compliance, optimize drug purchasing, and enhance patient services. As a 340B consulting agency, Ravin Consultants delves into practical strategies that healthcare providers can employ to leverage the 340B program effectively, maintain program integrity, and ultimately, support their mission to deliver quality care to underserved populations. Read More >